Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

DFS is a validated surrogate endpoint for OS in trials evaluating neoadjuvant chemotherapy or chemoradiotherapy in E/GEJ. DFS may be more useful as an endpoint when delays between recurrences and death become larger.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-02-07
DOI
https://doi.org/10.1016/j.ejca.2025.115292
Citations
3
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

Bryan Burmeister, Marc Ychou, Guillaume Piessen, Joel E. Tepper et al.
3 citations
European Journal of Cancer
Esophageal Cancer Research and Treatment
6.02
article

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

Bryan Burmeister, Marc Ychou, Guillaume Piessen, Joel E. Tepper, B. Mark Smithers, Val Gebski, Matthieu Faron, Nicolas Cabrit, Florent de Vathaire, Jean‐Pierre Pignon, Janine Thomas, P. Thirion, Jayne F. Tierney, Florian Lordick, D. Williaume, David Cunningham, Michele Valmasoni, Matthew Nankivell, Johanna van Sandick, Stefan Michiels, M. Cheugoua-Zanetsie, Simon Law, Magnus Nilsson, Michel Ducreux, Susan G. Urba, Xavier Paolettí, Jurjen J. Boonstra, Jian Fu, M. Stahl, Kathryn Winter, Bas P. L. Wijnhoven, Hong Yang, Déwi Vernerey
article en
3 citations

Abstract

DFS is a validated surrogate endpoint for OS in trials evaluating neoadjuvant chemotherapy or chemoradiotherapy in E/GEJ. DFS may be more useful as an endpoint when delays between recurrences and death become larger.

European Journal of CancerVol. 218
Centre National de la Recherche Scientifique (FR), Karolinska University Hospital (SE), University of Padua (IT), Inserm (FR), Sun Yat-sen University (CN), Trinity College Dublin (IE), Université de Lille (FR), Université Paris-Saclay (FR), Leiden University Medical Center (NL), Princess Alexandra Hospital (AU), Institut Gustave Roussy (FR), Erasmus MC (NL), Centre de recherche en Epidémiologie et Santé des Populations (FR), Centre Eugène Marquis (FR), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL), Kliniken Essen-Mitte (DE), Sun Yat-sen University Cancer Center (CN), NRG Oncology (US), University College London (GB), Institut Curie (FR), University of Hong Kong (HK)
Institut National Du Cancer, Medical Research Council
Openalex Percentile: Top 5%
Esophageal Cancer Research and Treatment
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.